Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations.
about
Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic reviewOutcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazoleAssessment of the impact of cotrimoxazole prophylaxis on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic reviewCotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority TrialLoss to Followup: A Major Challenge to Successful Implementation of Prevention of Mother-to-Child Transmission of HIV-1 Programs in Sub-Saharan Africa.National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and LinksDaily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South AfricaCD4(+) T cell count decreases by ethnicity among untreated patients with HIV infection in South Africa and SwitzerlandA randomized trial of prolonged co-trimoxazole in HIV-infected children in AfricaDoes trimethoprim-sulfamethoxazole prophylaxis for HIV induce bacterial resistance to other antibiotic classes? Results of a systematic review.Retrospective evaluation of cotrimoxazole use as preventive therapy in people living with HIV/AIDS in Boru Meda Hospital.Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China.Mortality among tuberculosis patients under DOTS programme: a historical cohort study.Improved survival with co-trimoxazole prophylaxis among people living with HIV/AIDS who initiated antiretroviral treatment in Henan Province, China.The effect of HIV on malaria in the context of the current standard of care for HIV-infected populations in Africa.Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapyCotrimoxazole prophylaxis and tuberculosis risk among people living with HIV.Developing an evidence-based, preventive care package for persons with HIV in Africa.Dual-targeted anti-TB/anti-HIV heterodimers.Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.Utilization of a basic care and prevention package by HIV-infected persons in Uganda.Incidence of Opportunistic Infections among HIV-Positive Adults on Highly Active Antiretroviral Therapy in a Teaching Hospital, India: Prospective Study.An 84-month observational study of the changes in CD4 T-lymphocyte cell count of 110 HIV/AIDS patients treated with traditional Chinese medicine.Implementing a rural programme of prevention of mother-to-child transmission of HIV in Zimbabwe: first 18 months of experience.Daily trimethoprim-sulfamethoxazole prophylaxis rapidly induces corresponding resistance among intestinal Escherichia coli of HIV-infected adults in Kenya.
P2860
Q21133667-BB365C35-03AA-4D4D-AA73-2A066267F379Q24678763-0EF5BD6A-0635-4AC1-B6FC-6B6F110E3027Q28084544-E747CEFC-9B42-4365-A437-7546718A801CQ28552031-327BE1C8-8A12-4F69-A761-85EB1E113CE1Q30486379-9B78F3A9-00B1-474F-8233-2F6A6A6EEAF4Q30501533-CB15F10F-022F-43A8-928F-002E8A918303Q33881449-EF995962-63D6-484E-A103-EF64CE150805Q34209707-254923DE-EC39-49CF-8EB5-06662D9FA755Q34664047-7B4EAD6E-3D2D-42D1-A74E-FA4F4DA5B59AQ34687538-987FF3DE-8088-4B41-820B-E7428F0788B1Q34762420-DB7C4EC8-7B24-4A9A-BECB-EAA4E683FE7FQ35089191-2896D09D-B64A-4852-A468-6300F2C1FF91Q35211308-1EEEC5BE-06FA-44E7-AA59-C0B5B77548A3Q36113498-C79F3A9C-0490-4F3E-82FD-02E7A35858FBQ36480371-C7576324-DC49-4B4C-902D-79D4BE365D8AQ36504556-66137951-B511-48D8-9F50-9FB35111F05DQ36628019-3C55FFB6-FA15-4F4F-93D5-99F407A10E5CQ37452075-F32F47EB-918F-4614-8E63-A7E14B87C911Q38456034-6C186774-A6D4-4F7D-B43E-497BA8CC8398Q38651946-7121E2D4-D7B1-48D9-AFD9-ABB177CC193DQ38872771-CE05F1B5-DB84-4777-8559-FA4A53594E65Q38877456-F1B41B25-9E29-47A3-9BA2-FD0BAC2EF4B9Q39041575-1E2C4449-297D-4454-ACFF-8A24493B880EQ41752887-7ACBC80B-4AA9-4CE3-A11F-6DBB99B2098CQ44959754-7DCB3E95-1583-4004-8187-54CABCD4C278Q54406685-9A5591E2-8489-4D64-84CF-675E260E4AB3
P2860
Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Initiating co-trimoxazole prop ...... al WHO/UNAIDS recommendations.
@en
Initiating co-trimoxazole prop ...... al WHO/UNAIDS recommendations.
@nl
type
label
Initiating co-trimoxazole prop ...... al WHO/UNAIDS recommendations.
@en
Initiating co-trimoxazole prop ...... al WHO/UNAIDS recommendations.
@nl
prefLabel
Initiating co-trimoxazole prop ...... al WHO/UNAIDS recommendations.
@en
Initiating co-trimoxazole prop ...... al WHO/UNAIDS recommendations.
@nl
P2093
P1433
P1476
Initiating co-trimoxazole prop ...... al WHO/UNAIDS recommendations.
@en
P2093
P304
P356
10.1097/00002030-200106150-00009
P407
P577
2001-06-01T00:00:00Z